Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes-Reference-Cited by-同舟云学术

Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes

Published:2019-07-21 Issue:11 Volume:21 Page:2394-2404
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Lega Iliana C.¹²³^ORCID,Bronskill Susan E.¹³⁴,Campitelli Michael A.³,Guan Jun³,Stall Nathan M.¹⁴⁵,Lam Kenneth¹,McCarthy Lisa M.¹⁴⁶,Gruneir Andrea¹³⁷,Rochon Paula A.¹²³⁴

Affiliation:

1. Women's College Research InstituteWomen's College Hospital Toronto Ontario Canada

2. Department of MedicineUniversity of Toronto Toronto Ontario Canada

3. ICES, Toronto Ontario Canada

4. Institute of Health Policy, Management, and EvaluationUniversity of Toronto Toronto Ontario Canada

5. Division of Geriatric Medicine, Department of MedicineUniversity of Toronto Ontario Canada

6. Leslie Dan Faculty of PharmacyUniversity of Toronto Ontario Canada

7. Department of Family MedicineUniversity of Alberta Edmonton Alberta Canada

Funder

Canadian Institutes of Health Research

Ontario Ministry of Health and Long-Term Care

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13820

Reference42 articles.

1. Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

2. Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise

3. Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial

4. Effect of Canagliflozin on Blood Pressure and Adverse Events Related to Osmotic Diuresis and Reduced Intravascular Volume in Patients With Type 2 Diabetes Mellitus

5. Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?;Heart Failure Clinics;2024-10

2. Comparative risk of infection of medications used for type 2 diabetes;Expert Opinion on Drug Safety;2024-09-11

3. Gender Differences in the Clinical Profile of Sodium-Glucose Cotransporter-2 Inhibitor-Related Urinary Tract Infections;Cureus;2024-08-23

4. SGLT2 inhibitor use in the management of feline diabetes mellitus;Journal of Veterinary Pharmacology and Therapeutics;2024-07-02

5. Prevalence of genitourinary symptoms in people with type 2 diabetes initiated with SGLT2 inhibitors;International Journal of Diabetes in Developing Countries;2024-06-25